MedTrace Logo

Supporting Attendance for Facility Delivery and Infant Health

NCT03023033 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1505

Last updated 2021-02-08

No results posted yet for this study

Summary

The goal of this proposed intervention study is to increase the proportion of HIV positive and HIV negative pregnant women who deliver in a facility, the proportion of HIV exposed infants (HEI) who receive nevirapine (NVP) within 48 hours of delivery, and the proportion of HEI who are bled for HIV polymerase chain reaction (PCR) deoxyribonucleic acid (DNA) testing within 8 weeks of age.

Conditions

Interventions

BEHAVIORAL

mHealth messaging

SMS appointment reminders and health messaging via mobile phones

BEHAVIORAL

Transport Payments

A payment scaled to reflect the cost of typical return transport fare for residents of the clinic catchment area

Sponsors & Collaborators

  • Population Council

    collaborator OTHER

  • Ministry of Health, Tanzania

    collaborator OTHER_GOV

  • Elizabeth Glaser Pediatric AIDS Foundation

    lead OTHER

Principal Investigators

  • Godfrey Woelk, MCOMMH, PhD · Elizabeth Glaser Pediatric AIDS Foundation

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2016-03-31
Completion
2016-11-30

Countries

  • Tanzania

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03023033 on ClinicalTrials.gov